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Some patients with intracranialJL
aneurysms have a reduced 
type Ill/type I collagen ratio
A  case-control study
J.S.P. van den Berg, MD; M. Limburg, MD, PhD; G. Pals, PhD; F. Arwert, PhD; A. Westerveld, PhD;
R.C.M. Hennekam, MD, PhD; and K.W. Albrecht, MD
Article abstract—A reduced production of type III collagen has been reported in previous studies to be associated with 
intracranial aneurysms. The purpose of this prospective case-control study was to assess the possible role of a reduced 
type III collagen production as a risk factor for having an intracranial aneurysm. The study group consisted of 41 
consecutively admitted patients with intracranial aneurysms. Intracranial aneurysms were demonstrated by intra- 
arterial digital subtraction cerebral angiography or during operation. The control group consisted of 41 healthy volunteers 
matched for age and sex. Fibroblasts were cultured from skin biopsies from patients and control subjects, and the type 
Ill/type I collagen ratios were determined. The type Ill/type I collagen ratios in the controls ranged from 5.5 to 19.8%, with 
a median ratio of 10%, and none had a ratio below 5.5%. The type Ill/type I collagen ratios in patients ranged from 1.1 to 
25.1%, with a median ratio of 10.5%, and eight patients (19,5%) had a low (<5.5%) ratio (p = 0.005, Fisher's exact test). 
Our findings support the hypothesis that a reduced production of type III collagen may contribute to the formation of 
intracranial aneurysms in some patients.
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Subarachnoid hemorrhages represent approximately 
7% of all strokes1 and account for 45% of the strokes 
between the ages of 35 and 44 years.2 Over the last 
four decades, the incidence of subarachnoid hemor­
rhages has not changed, and the mortality rate has 
remained high.1»3 Many survivors remain in a dis­
abled state.1 Most subarachnoid hemorrhages are 
caused by rupture of an intracranial aneurysm.4 
Early detection and preventive surgery may lead to 
an increased lifespan.5 Mortality and morbidity for 
surgery of unruptured intracranial aneurysms are 
relatively low.6 Understanding of the underlying 
mechanisms leading to the formation of intracranial 
aneurysms is important in view of the development 
of preventive strategies.
One hypothesis considers the pathogenesis of in­
tracranial aneurysms to be a multifactorial process 
in which both intrinsic factors, such as vessel wall 
abnormalities, and extrinsic factors, such as hyper­
tension, play a role.7'9 A reduced production of type 
III collagen is a possible candidate for such an intrin­
sic factor. Several observations suggest a relation­
ship between a defect of type III collagen and the 
pathogenesis of intracranial aneurysms. Type III col­
lagen is responsible for the tensile strength of the 
arteries, especially when the strain on the vessel 
wall becomes high.10-12 Mutations in the type III col­
lagen gene, encoding the type III procollagen, pro­
duces the Ehlers-Danlos type IV phenotype.13 
Ehlers-Danlos type IV patients show a diversity of 
clinical symptoms, including skin laxity and rup­
tured intracranial aneurysms.14’15
Several protein-based studies have revealed a re­
lationship between a reduced production of type III 
collagen and intracranial aneurysms.16-21 However, 
Kuivaniemi et al.,22 using DNA sequence analysis of 
part of the gene encoding the triple-helical domain of 
type III collagen in 40 patients with intracranial an­
eurysms, did not observe mutations and concluded 
that structural mutations in the gene encoding for 
type III collagen are not a common cause of intracra­
nial aneurysms.
To investigate a possible significance of a reduced 
production of type III collagen on the protein level, 
we determined the type Ill/type I collagen ratios 
from skin fibroblasts of patients with intracranial 
aneurysms and compared these with type Ill/type I 
collagen ratios in control subjects. Our study ques-
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tions were as follows: is the presence of intracranial 
aneurysms associated with a reduced production of 
type III collagen, and, if so, is there a difference in 
the clinical features of these patients with a normal 
and reduced production of type III collagen?
Methods. In a prospective study, we included all consecu­
tive patients with an intracranial aneurysm admitted to the 
Department of Neurosurgery of the Academic Medical Center 
in Amsterdam. The diagnosis had to be con-firmed by a three- 
vessel intra-arterial digital subtraction angiography or at 
craniotomy. Hypertension, polycystic kidney disease, or other 
renal abnormalities; symptoms fitting Marfan syndrome; 
Ehlers-Danlos syndrome type IV; pseudoxanthoma elasti- 
cum; and family history of the same factors were recorded 
from the medical history. Patients were examined by two 
experienced clinical geneticists (R.C.M.H. and the late J.W. 
Oorthuys) for signs of Ehlers-Danlos syndrome type IV, 
Marfan syndrome, and pseudoxanthoma elasticum. The cere­
bral angiograms were independently studied by two investi­
gators who scored the localization and size of the aneurysm. 
The largest measured diameter in any projection was taken 
as the size of the aneurysm. In case of any discrepancy, the 
angiograms were discussed, and a consensus between the 
two observers was obtained. The control group consisted of 41 
healthy volunteers (personnel from the Academic. Medical 
Center) matched for age and gender and without a history of 
intracranial aneurysms. The study was approved by the 
Hospital Medical Ethical Committee.
Biochemical and molecular studies. After informed 
consent, a skin biopsy was taken for fibroblast culture. 
Fibroblasts were cultured to confluence in 25 cm2 flasks in 
Ham’s F10 (Life Technologies, Bethesda, MD) with 10% 
fetal calf serum. Metabolic labeling was performed for 20 
hours in 2 mL BME prolin free media (Life Technologies) 
containing 5% dialyzed fetal calf serum, 37 jxg/mL L- 
ascorbic acid, 2 fxCi/ml L-[U14C]-Prolin (Amersham Inter­
national, Little Chalton, U.K.). After ethanol precipitation 
of 333-fiL aliquots of media, the pellets were dissolved in 
150 |xL 0.5 M acetic acid. One aliquot of each sample was 
treated with pepsin for the analysis of collagen; untreated 
aliquots were used for procollagen. The cells were 
trypsinized, centrifuged, washed, and frozen as dry pellets. 
The pellets were homogenized in 150 jjlL  0.5 M acetic acid. 
After centrifugation, the supernatants were used for elec­
trophoresis. After liquid scintillation counting, 20,000 cpm 
aliquots of the samples (between 5 and 10 \lL) were lyoph- 
ilized, dissolved in 20 |jiL of sample loading buffer (Pro- 
mega Corp., Madison, WI), and subjected to SDS-PAGE in 
a Protean II electrophoresis system (Bio-Rad, Hercules, 
CA). After 90 minutes at 200 V (10°C), the samples were 
reduced in the gel by addition of 30 fjiL of dithiothreitol 
solution (7.7 mg/mL in 40% sacharose) in each slot (reduc­
tion of samples before electrophoresis leads to overlap of 
type I and III collagens). After another 90 minutes at 400 
V, the gels were dried and analyzed with a Phosphor- 
Imager (Molecular Dynamics, Sunny Valley, CA). The sig­
nals from the radioactively labeled collagen chains were 
quantified in arbitrary but linear units using a Phosphor- 
Imager.20 The ratio of type IH/type I collagen, defined as 
the al(III)/[al(I) 4- a2(I) + al(III)] ratio, was then com­
puted. In all subjects, the final ratios are the average re-
A
suits of three independent separate labeling experiments.
All collagen determinations were done within four pas­
sages of the biopsy.
All type Ill/type I collagen ratios encountered in the 
control group were considered to represent normal values. 
As a result, all values found in the patient group that were 
below the lowest value of the control group were consid­
ered to represent abnormally low type III/type I ratios. In 
patients with abnormally low ratios of type IH/type I colla­
gen, intracellular type III procollagen was assessed by 
electrophoretic analysis of the content of lysed cells. Struc­
turally abnormal type III procollagen has an abnormal 
electrophoretic mobility.24
In the statistical analyses, Fisher's exact test and Wil- 
coxon rank sum test were used.
Results. Most patients (38/41) presented with a rup­
tured intracranial aneurysm. In all patients except one, a 
cerebral angiography was performed. This patient was op­
erated on immediately because of a rapid clinical deterio­
ration, and the presence of an aneurysm was confirmed. In 
the three patients without presenting subarachnoid hem­
orrhage, the indications for a cerebral angiography were 
intracerebral hemorrhage, atypical facial pain with a posi­
tive family history for intracranial hemorrhages, and head­
ache with transient neurologic signs of visual disturbance 
and dysarthria. In this patient, brain CT showed a lesion 
compatible with an intracranial aneurysm. The median 
age of the patients was 49 years (ranging from 26 to 79 
years). Other characteristics of the patients are shown in 
table 1. The three patients with a positive family history 
for polycystic kidney disease also had a positive family 
history for hypertension. Cerebral angiography in one pa­
tient also showed a small arteriovenous malformation. The 
median age of the control subjects was 43 years (ranging 
from 26 to 56 years), and there were 16 men and 25 
women.
The results of the protein analysis are presented in 
figure 1. The type Ill/type I collagen ratios in the control 
subjects ranged from 5.5 to 19.8%, with a median of 10%. 
The resulting cutoff value below which type IH/type I col­
lagen ratios will be considered abnormally low was 5.5%. 
The type IH/type I collagen ratios in the patients ranged 
from 1.1 to 25.1%, with a median of 10.5%, and eight 
patients (19.5%) had a very low (<5.5%) ratio (figure 2). 
This difference is statistically significant (p = 0.005, Fish­
er’s exact test). The ratios of the type Ill/type I collagen in 
patients and control subjects were compared on a group 
level and there was no evidence that the samples of the 
ratios of the patients and control subjects were derived 
from different distributions (two-tailed p = 0.51, Wilcoxon 
rank sum test).
The patient with the small arteriovenous malformation 
had a normal type Ill/type I collagen ratio. In fibroblasts 
from the eight patients with type Ill/type I collagen ratios 
of less than 5.5%, intracellular type III pro collagen was 
found to be low, and there were no indications of an excess 
of structurally abnormal type III procollagen.
We examined whether patients with a very low type 
Ill/type I collagen ratio (<5.5%) differed in clinical charac­
teristics from the patients with a normal type Ill/type I 
collagen ratio (table 2). Apart from a trend favoring pa­
tients with a very low type Ill/type I collagen ratio to have 
a positive family history for polycystic kidney disease, no 
statistically significant differences were found.
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T ab le  1 Characteristics o f  41 consecutive patients with  
intracranial aneurysms
Number of patients 
(% of total)
Men:women 16:25
Polycystic kidney disease 2(5)
Hypertension 19(46)
Family history
Sub arachnoid hemorrhage 4(10)
Hypertension 20 (49)
Polycystic kidney disease 3(7)
Multiple aneurysms 6(15)
Localization of aneurysms
ACA left/right 0/4
ACoA 14
ICA left/right 4/5
MCA left/right 6/6
Basilar artery 5
PICA left/right 2/1
Clinical outcome
Discharge to rehabilitation center 2(5)
Discharge to nursing home 2(5)
Home 31 (75)
Deceased 6(15)
ACA = anterior cerebral artery; ACoA = anterior communicating 
artery; ICA = internal carotid artery; MCA = middle cerebral 
artery; PICA = posterior inferior cerebellar artery.
Discussion* We examined a possible relationship 
between intracranial aneurysms and a reduced pro­
duction of type III collagen through protein analysis. 
We found no difference in the median type Ill/type I 
collagen ratios between patients and control sub­
jects. However, we found significantly more persons 
with low type Ill/type I collagen ratios in the patient 
group than in the control group. This is in keeping 
with the a priori formulated hypothesis. We exam­
ined the clinical characteristics of patients with nor­
mal and low type Ill/type I collagen ratios and found 
no differences.
Using protein analysis, Leblanc et al.215,26 found 
normal type III collagen production in five patients 
with familial intracranial aneurysms of different 
families. However, there are several reports finding 
a reduced production of type III collagen in fibro­
blasts or low amounts of collagen type III in arterial 
wall samples of patients with intracranial 
aneurysms.16*21 Neil-Dwyer et al.16 studied a small 
population. Carboxymethyl cellulose chromatogra­
phy was performed in four control subjects and in 
seven patients, and gel scanning was used in four 
control subjects and seven patients. They concluded 
that 11 of 17 patients were type III collagen defi­
cient. 0stergaard and Oxlun17 used postmortem sam­
ples of the middle cerebral and brachial arteries of
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Figure I. Type III ¡type I  collagen ratios (coL III  %) in 41 
control subjects (c) and 41 consecutive patients with intra­
cranial aneurysms (p aneurysm.).
14 patients who died of a ruptured intracranial an­
eurysm and similar samples of a control group of 14 
patients who died of causes unrelated to aneurysm 
rupture. Electrophoresis and spectrophotometry re­
vealed a reduced amount of type III collagen in sam­
ples of the middle cerebral arteries in six patients of 
the ruptured aneurysm group and in none of the 
control group. However, the studied population was 
biased because only deceased patients were included, 
There was a difference between the type IH/type I 
collagen ratios determined from the middle cerebral 
artery and the brachial artery taken from the same 
patient. The authors did not supply explanation for 
this disparity. Majamaa et al.18 determined the syn­
thesis of type III collagen in skin fibroblast cultures 
from 11 patients with an intracranial aneurysm 
(plus 9 control subjects) and found no reduced pro-
T a b le  2  Characteristics o f  pa tien ts  w ith  intracranial aneurysm s  
and normal type III/type I  collagen ratios compared with pa tien ts  
with low (<5.5%) type I I I / type I  collagen ratios
Type Ill/type I collagen 
ratio Normal Low p.i.
Number of patients 33 8
Median age (and range) 50 (30-69) 47 (26-66) 0.64
in years
Men: women 14:19 2:6 0.45
Polycystic kidney 1 (3%) 1 (13%) 0.36
disease
Hypertension 14 (42%) 5 (67%) 0.23
Family history
Subarachnoid 3 (9%) 1 (17%) 1.00
hemorrhage
Hypertension 16 (48%) 4 (50%) 1.00
Polycystic kidney 1 (3%) 2 (25%) 0.11
disease
Localization of 
aneurysms
Anterior circulation 30 9
ACA left/right 0/4 0/0
ACoA 13 1
ICA left/right 3/3 1/2
MCA left/right 2/5 4/1
Posterior circulation 8 0 0.19t
Basilar artery 5 0
PICA left/right 2/1 0/0
Size of aneurysms
Median (and range in 0.7 (0.4-2.0) 0.6 (0.2-2.5) 0,64
cm)
Multiple aneurysms 5 1 1.00
Outcome
Good 26 7
Home 24 (73%) 7 (88%)
Rehabilitation 2 (6%) 0 (0%)
Poor 7 1 0.68Î
Nursing home 2 (6%) 0 (0%)
Deceased 5 (15%) 1(12%)
* Fisher’s exact test, two-tailed (for age and size, Wilcoxon rank 
sum test).
t Comparison between anterior and posterior circulation, 
x Comparison between good and poor outcome.
ACA = anterior cerebral artery; ACoA = anterior communicating 
artery; ICA = internal carotid artery; MCA = middle cerebral 
artery; PICA = posterior inferior cerebellar artery.
duction of type III collagen, although they reported a 
production of unstable type III collagen in 2 patients. 
In this study, six patients had a first- or second- 
degree relative with an intracranial aneurysm, in­
cluding the two patients with unstable type III 
collagen production. In another study by Majamaa et 
al.19 in 12 patients with aneurysmal subarachnoid
hemorrhages (plus 8 control subjects), protein analy­
sis showed combined procollagen production in two 
cell lines to be reduced. Despite widely varying 
methodology and several possible flaws in design 
and conduct, these studies indicated a role of re­
duced production of type III collagen in the forma­
tion of intracranial aneurysms.
Two patients with a low type Ill/type I collagen 
ratio (<5.5%) from our study also had a positive 
family history of polycystic kidney disease, and one 
had polycystic kidney disease. Adult polycystic 
kidney disease (ADPKD) is a disease with a firmly 
established association with intracranial aneu­
rysms.27'29 Two loci for ADPKD are known and have 
previously been mapped (PKD1 on chromosome 16 
and PKD2 on chromosome 4).30-31 At least a third 
locus for ADPKD is still unmapped.32 The gene for 
type III collagen is located on chromosome 2.33 A 
genetic relation between ADPKD and EDS type IV is 
possible.
Five of eight patients with a low type III collagen 
had one or more risk factors for intracranial aneu­
rysms. This is in keeping with the theory that intra­
cranial aneurysms have a multifactorial cause. This 
theory is based on the following clinical and epidemi­
ologic data. Independent acquired risk factors for in­
tracranial aneurysms are smoking, hypertension, 
and age.7-9 If twins have intracranial aneurysms, 
they often occur in analogous or mirrored locations.34 
Familial aggregation of intracranial aneurysms has 
been described on several occasions. First-degree rel­
atives of patients with an intracranial aneurysm in 
particular have a two- to threefold increased chance 
of harboring an aneurysm.35,36 Familial aneurysms 
have characteristics different from those that occur 
spontaneously. They occur at a lower age, are located 
less often in the anterior cerebral artery ramifica­
tions, and may rupture at a smaller size. Among 
family members, aneurysms arise more often from 
the same arterial distribution and rupture more of­
ten within the same decade of life.37,38 However, indi­
cations exist for genetic heterogeneity. In a recent 
review on the pattern of inheritance in all published 
families, no single genetic mode could be identified.39 
Other links to the genetic nature of intracranial an­
eurysms are the abovementioned association with 
ADPKD and with heritable connective tissue 
disorders.27'29,40 Intracranial aneurysms occur in the 
setting of pseudoxanthoma elasticum, osteogenesis 
imperfecta, Ehlers-Danlos syndrome type IV, and 
neurofibromatosis type 1. The suggestion of Adam­
son et al.41 on atherosclerosis being a single cause 
seems less likely.
Our determinations of collagen production in cell 
cultures will give a rough indication of the various 
processes happening in the arterial walls. However, 
our data suggest that a defect in the production of 
type III collagen plays a role in the pathogenesis of 
intracranial aneurysms. Although the reduced type 
Ill/type I collagen ratios are likely related to type III 
collagen deficiency, we have not demonstrated this.
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